Lisa Gill
Stock Analyst at J.P. Morgan
(4.54)
# 1,024
Out of 4,988 analysts
448
Total ratings
59.5%
Success rate
9%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Reiterated: Buy | n/a | $322.73 | - | 16 | Aug 26, 2026 | |
| AGL agilon health | Reiterated: Sell | $21 → $85 | $89.17 | -4.68% | 16 | Aug 24, 2026 | |
| PGNY Progyny | Reiterated: Hold | $27 → $30 | $27.01 | +11.07% | 5 | Aug 21, 2026 | |
| CAH Cardinal Health | Reiterated: Hold | $260 | $226.34 | +14.87% | 24 | Aug 17, 2026 | |
| LFST LifeStance Health Group | Reiterated: Hold | $9 → $13 | $12.61 | +3.09% | 13 | Aug 14, 2026 | |
| OMDA Omada Health | Reiterated: Buy | $26 → $30 | $19.83 | +51.29% | 2 | Aug 14, 2026 | |
| CVS CVS Health | Reiterated: Buy | $118 | $90.27 | +30.72% | 33 | Aug 12, 2026 | |
| MDLN Medline | Reiterated: Buy | $53 → $46 | $32.12 | +43.21% | 3 | Aug 12, 2026 | |
| COR Cencora | Reiterated: Buy | $419 → $390 | $309.41 | +26.05% | 28 | Aug 10, 2026 | |
| HUM Humana | Rated: Hold | $316 → $393 | $384.52 | +2.21% | 23 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,015 → $1,042 | $879.57 | +18.47% | 47 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $276.00 | - | 22 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $220 → $250 | $247.45 | +1.03% | 19 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $466 → $516 | $375.21 | +37.52% | 29 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $411 → $476 | $414.26 | +14.90% | 19 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $40 → $33 | $24.50 | +34.69% | 15 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 | $6.28 | +11.46% | 28 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $35 | $20.09 | +74.22% | 18 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.40 | - | 8 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $23 | $8.70 | +164.37% | 12 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $6 → $10 | $13.97 | n/a | 6 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7 → $6 | $1.03 | n/a | 17 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $31 | $35.53 | n/a | 3 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $26.51 | n/a | 1 | Jun 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $28 → $27 | $13.34 | n/a | 9 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $110 | $83.08 | n/a | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $6 → $5 | $10.70 | n/a | 7 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $18 | $42.06 | n/a | 3 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $82 → $80 | $67.10 | n/a | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $19 | $10.70 | n/a | 2 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $257 → $379 | $429.04 | n/a | 5 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $378 | $205.09 | n/a | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $172 | $261.90 | n/a | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $226 | $180.75 | n/a | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $88 → $83 | $85.04 | n/a | 5 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $9 | $4.54 | n/a | 1 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $3.67 | n/a | 2 | Aug 5, 2016 |
Labcorp Holdings
Aug 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $322.73
Upside: -
agilon health
Aug 24, 2026
Reiterated: Sell
Price Target: $21 → $85
Current: $89.17
Upside: -4.68%
Progyny
Aug 21, 2026
Reiterated: Hold
Price Target: $27 → $30
Current: $27.01
Upside: +11.07%
Cardinal Health
Aug 17, 2026
Reiterated: Hold
Price Target: $260
Current: $226.34
Upside: +14.87%
LifeStance Health Group
Aug 14, 2026
Reiterated: Hold
Price Target: $9 → $13
Current: $12.61
Upside: +3.09%
Omada Health
Aug 14, 2026
Reiterated: Buy
Price Target: $26 → $30
Current: $19.83
Upside: +51.29%
CVS Health
Aug 12, 2026
Reiterated: Buy
Price Target: $118
Current: $90.27
Upside: +30.72%
Medline
Aug 12, 2026
Reiterated: Buy
Price Target: $53 → $46
Current: $32.12
Upside: +43.21%
Cencora
Aug 10, 2026
Reiterated: Buy
Price Target: $419 → $390
Current: $309.41
Upside: +26.05%
Humana
Aug 10, 2026
Rated: Hold
Price Target: $316 → $393
Current: $384.52
Upside: +2.21%
Aug 10, 2026
Reiterated: Buy
Price Target: $1,015 → $1,042
Current: $879.57
Upside: +18.47%
Jul 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $276.00
Upside: -
Jul 28, 2026
Rated: Hold
Price Target: $220 → $250
Current: $247.45
Upside: +1.03%
Jul 21, 2026
Reiterated: Buy
Price Target: $466 → $516
Current: $375.21
Upside: +37.52%
Jun 8, 2026
Reiterated: Buy
Price Target: $411 → $476
Current: $414.26
Upside: +14.90%
May 4, 2026
Rated: Buy
Price Target: $40 → $33
Current: $24.50
Upside: +34.69%
Mar 13, 2026
Rated: Hold
Price Target: $7
Current: $6.28
Upside: +11.46%
Mar 6, 2026
Reiterated: Buy
Price Target: $33 → $35
Current: $20.09
Upside: +74.22%
Feb 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.40
Upside: -
Dec 17, 2025
Reiterated: Buy
Price Target: $20 → $23
Current: $8.70
Upside: +164.37%
Sep 18, 2025
Upgraded: Hold
Price Target: $6 → $10
Current: $13.97
Upside: n/a
Aug 27, 2025
Reiterated: Sell
Price Target: $7 → $6
Current: $1.03
Upside: n/a
Aug 21, 2025
Reiterated: Buy
Price Target: $30 → $31
Current: $35.53
Upside: n/a
Jun 6, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $26.51
Upside: n/a
May 16, 2025
Reiterated: Hold
Price Target: $28 → $27
Current: $13.34
Upside: n/a
Mar 19, 2025
Reiterated: Buy
Price Target: $120 → $110
Current: $83.08
Upside: n/a
Dec 17, 2024
Downgraded: Sell
Price Target: $6 → $5
Current: $10.70
Upside: n/a
Dec 17, 2024
Downgraded: Hold
Price Target: $40 → $18
Current: $42.06
Upside: n/a
Nov 12, 2024
Reiterated: Hold
Price Target: $82 → $80
Current: $67.10
Upside: n/a
Aug 30, 2024
Reiterated: Hold
Price Target: $18 → $19
Current: $10.70
Upside: n/a
Aug 9, 2024
Reiterated: Hold
Price Target: $257 → $379
Current: $429.04
Upside: n/a
Aug 9, 2024
Reiterated: Buy
Price Target: $378
Current: $205.09
Upside: n/a
Aug 9, 2024
Reiterated: Buy
Price Target: $172
Current: $261.90
Upside: n/a
Aug 9, 2024
Reiterated: Hold
Price Target: $226
Current: $180.75
Upside: n/a
Aug 9, 2023
Reiterated: Hold
Price Target: $88 → $83
Current: $85.04
Upside: n/a
Jul 12, 2021
Downgraded: Sell
Price Target: $9
Current: $4.54
Upside: n/a
Aug 5, 2016
Reiterated: Buy
Price Target: $26
Current: $3.67
Upside: n/a